Population Pharmacokinetics of Cotadutide in Subjects with Type 2 Diabetes
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Pharmacokinetics"
DOI: 10.1007/s40262-021-01094-y
Abstract: Cotadutide is a balanced dual glucagon-like peptide-1/glucagon receptor agonist under development for the treatment of nonalcoholic steatohepatitis and chronic kidney disease with type 2 diabetes. The objectives of the analysis were to characterize the population… read more here.
Keywords: population pharmacokinetics; type diabetes; pharmacokinetics cotadutide; cotadutide ... See more keywords
Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study
Sign Up to like & getrecommendations! Published in 2021 at "Diabetes Care"
DOI: 10.2337/dc20-2151
Abstract: OBJECTIVE Cotadutide, a dual GLP-1 and glucagon receptor agonist, is under development for nonalcoholic steatohepatitis (NASH) and chronic kidney disease with type 2 diabetes. The effects of cotadutide on hepatic and metabolic parameters were evaluated… read more here.
Keywords: obesity type; cotadutide; overweight obesity; type diabetes ... See more keywords